Get the Stockscreener App
20.57
2.54%
0.51
After Hours:
20.11
-0.46
-2.24%
Arrowhead Pharmaceuticals Inc Stock (ARWR) Forecast
The Arrowhead Pharmaceuticals Inc (ARWR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $61.14, representing a +197.21% increase from the current price of $20.57. The highest analyst price target is $77.37, and the lowest is $44.90.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ARWR Price Target
Average 50.35
(+144.77% Upside)
Is Arrowhead Pharmaceuticals Inc (ARWR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 55.07 | Neutral |
| STOCH(9,6) | 30.24 | Neutral |
| STOCHRSI(14) | 81.02 | Sell |
| MACD(12,26) | -0.0816 | Buy |
| ADX(14) | 14.74 | Neutral |
| William %R | -38.84 | Neutral |
| CCI(14) | 19.33 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
19.92
Buy
|
19.97
Buy
|
| MA20 |
19.82
Buy
|
19.94
Buy
|
| MA50 |
20.48
Buy
|
20.79
Sell
|
| MA100 |
23.26
Sell
|
22.37
Sell
|
| MA200 |
25.38
Sell
|
24.38
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, ARWR could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on ARWR, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 55.07 indicates that ARWR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 30.24 indicates that ARWR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 81.02 indicates that ARWR is oversold. This suggests that ARWR price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.74 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 19.33 indicates that ARWR is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ARWR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Arrowhead Pharmaceuticals Inc financial reports and earnings history, Arrowhead Pharmaceuticals Inc (ARWR) stock could reach $34.92 by 2030, $48.84 by 2040 and $69.25 by 2050. See the projected annual prices until 2050 of the Arrowhead Pharmaceuticals Inc stock below:
- Arrowhead Pharmaceuticals Inc (ARWR) is expected to reach an average price of $37.79 in 2035, with a high prediction of $38.37 and a low estimate of $31.52. This indicates an $83.73% rise from the last recorded price of $20.57.
- Arrowhead Pharmaceuticals Inc (ARWR) stock is projected to chart a bullish course in 2040, with an average price target of $48.17, representing an $134.20% surge from its current level. The forecast ranges from a conservative $37.38 to a sky-high $48.84.
- Our analysts predict Arrowhead Pharmaceuticals Inc (ARWR) to jump 134.92% by 2045, soaring from $46.29 to an average price of $48.32, potentially reaching $56.56. While $46.29 is the low estimate, the potential upside is significant.
- Arrowhead Pharmaceuticals Inc (ARWR) stock is expected to climb by 2050, reaching an average of $67.87, a $229.92% jump from its current level. However, a wide range of estimates exists, with high and low targets of $69.25 and $59.38, respectively, highlighting the market's uncertainty.
Arrowhead Pharmaceuticals Inc Stock (ARWR) Year by Year Forecast
Arrowhead Pharmaceuticals Inc Stock (ARWR) Price Forecast for 2024
Our forecast for ARWR stock price in 2024 now indicates an average price target of $49.29 with a high forecast of $77.37 and a low forecast of $21.21. The average prediction reflects an increase of +139.62% from the last recorded price of $20.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $71.09 | $44.90 | $77.37 | +245.60% |
Arrowhead Pharmaceuticals Inc Stock (ARWR) Price Forecast for 2025
Arrowhead Pharmaceuticals Inc Stock (ARWR) is expected to reach an average price of $49.64 in 2025, with a high prediction of $75.95 and a low estimate of $23.33. This indicates an +141.32% rise from the last recorded price of $20.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $65.41 | $64.54 | $75.95 | +217.99% |
| February, 2025 | $45.78 | $44.70 | $65.08 | +122.56% |
| March, 2025 | $38.07 | $37.48 | $50.22 | +85.05% |
| April, 2025 | $31.73 | $23.33 | $40.96 | +54.26% |
| May, 2025 | $42.84 | $29.61 | $43.84 | +108.27% |
| June, 2025 | $39.69 | $35.34 | $43.83 | +92.96% |
| July, 2025 | $40.59 | $34.68 | $42.80 | +97.34% |
| August, 2025 | $48.37 | $39.50 | $50.11 | +135.16% |
| September, 2025 | $44.10 | $43.43 | $55.87 | +114.40% |
| October, 2025 | $39.92 | $37.89 | $50.42 | +94.09% |
| November, 2025 | $46.95 | $36.75 | $57.01 | +128.26% |
| December, 2025 | $61.21 | $46.34 | $66.66 | +197.55% |
Arrowhead Pharmaceuticals Inc Stock (ARWR) Price Forecast for 2026
The predicted value for Arrowhead Pharmaceuticals Inc (ARWR) in 2026 is set at an average of $78.81. Estimates vary from a peak of $97.65 to a trough of $59.97, indicating an +283.12% surge from the present price of $20.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $66.91 | $59.97 | $76.41 | +225.26% |
| February, 2026 | $84.08 | $65.13 | $85.98 | +308.77% |
| March, 2026 | $84.67 | $74.04 | $90.68 | +311.64% |
| April, 2026 | $93.46 | $78.97 | $96.54 | +354.33% |
| May, 2026 | $71.36 | $66.94 | $93.32 | +246.89% |
| June, 2026 | $66.12 | $64.60 | $75.06 | +221.42% |
| July, 2026 | $76.81 | $64.49 | $81.25 | +273.40% |
| August, 2026 | $92.70 | $74.04 | $94.63 | +350.64% |
| September, 2026 | $71.14 | $64.00 | $97.65 | +245.84% |
| October, 2026 | $68.96 | $65.59 | $75.01 | +235.24% |
| November, 2026 | $71.14 | $61.93 | $72.42 | +245.83% |
| December, 2026 | $66.54 | $64.25 | $73.67 | +223.48% |
Arrowhead Pharmaceuticals Inc Stock (ARWR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Arrowhead Pharmaceuticals Inc (ARWR) is $59.91, with a high forecast of $88.88 and a low forecast of $30.94. This indicates an +191.25% increase from the last price of $20.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $70.07 | $61.97 | $71.98 | +240.64% |
| February, 2027 | $75.16 | $67.16 | $88.88 | +265.38% |
| March, 2027 | $73.72 | $67.51 | $78.83 | +258.39% |
| April, 2027 | $61.88 | $59.35 | $75.21 | +200.83% |
| May, 2027 | $53.83 | $50.76 | $60.54 | +161.69% |
| June, 2027 | $47.01 | $43.51 | $60.33 | +128.55% |
| July, 2027 | $50.09 | $42.99 | $52.86 | +143.52% |
| August, 2027 | $46.77 | $46.12 | $55.22 | +127.38% |
| September, 2027 | $38.32 | $31.99 | $48.72 | +86.31% |
| October, 2027 | $33.25 | $30.94 | $39.86 | +61.66% |
| November, 2027 | $45.87 | $33.75 | $47.59 | +123.01% |
| December, 2027 | $51.44 | $43.01 | $52.23 | +150.09% |
Arrowhead Pharmaceuticals Inc Stock (ARWR) Price Forecast for 2028
In 2028, Arrowhead Pharmaceuticals Inc (ARWR) is projected to reach an average price of $39.98, with a high projection of $52.64 and a low estimate of $27.33. This indicates an +94.38% rise from the last price of $20.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $43.58 | $41.58 | $52.64 | +111.88% |
| February, 2028 | $37.22 | $33.77 | $44.06 | +80.96% |
| March, 2028 | $39.00 | $34.20 | $40.13 | +89.57% |
| April, 2028 | $33.70 | $33.01 | $41.26 | +63.81% |
| May, 2028 | $42.51 | $31.95 | $42.99 | +106.65% |
| June, 2028 | $37.98 | $32.73 | $45.24 | +84.62% |
| July, 2028 | $37.35 | $36.29 | $41.93 | +81.56% |
| August, 2028 | $30.55 | $29.78 | $39.38 | +48.51% |
| September, 2028 | $30.42 | $27.33 | $32.11 | +47.87% |
| October, 2028 | $45.64 | $29.48 | $46.74 | +121.86% |
| November, 2028 | $40.32 | $36.62 | $45.62 | +96.01% |
| December, 2028 | $39.94 | $38.80 | $41.65 | +94.16% |
Arrowhead Pharmaceuticals Inc Stock (ARWR) Price Forecast for 2029
The 2029 price forecast for Arrowhead Pharmaceuticals Inc Stock (ARWR) is $34.55 on average, with a high prediction of $44.19 and a low estimate of $24.91. This represents an +67.95% increase from the previous price of $20.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $38.81 | $37.01 | $40.72 | +88.68% |
| February, 2029 | $32.21 | $31.13 | $38.75 | +56.59% |
| March, 2029 | $33.23 | $31.06 | $35.45 | +61.55% |
| April, 2029 | $30.92 | $27.76 | $33.36 | +50.31% |
| May, 2029 | $31.29 | $27.20 | $32.63 | +52.12% |
| June, 2029 | $27.51 | $25.01 | $34.04 | +33.74% |
| July, 2029 | $34.95 | $27.41 | $36.03 | +69.91% |
| August, 2029 | $36.46 | $34.00 | $44.19 | +77.26% |
| September, 2029 | $35.97 | $32.87 | $37.67 | +74.85% |
| October, 2029 | $31.59 | $31.38 | $41.10 | +53.59% |
| November, 2029 | $26.72 | $26.14 | $33.47 | +29.92% |
| December, 2029 | $26.87 | $24.91 | $29.08 | +30.63% |
Arrowhead Pharmaceuticals Inc Stock (ARWR) Price Forecast for 2030
Arrowhead Pharmaceuticals Inc Stock (ARWR) is expected to reach an average price of $53.06 in 2030, with a high forecast of $81.15 and a low forecast of $24.96. This signifies an +157.93% surge from the last price of $20.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $33.38 | $24.96 | $34.92 | +62.29% |
| February, 2030 | $34.61 | $33.12 | $36.14 | +68.27% |
| March, 2030 | $36.57 | $34.39 | $38.18 | +77.79% |
| April, 2030 | $41.45 | $35.01 | $44.23 | +101.51% |
| May, 2030 | $35.76 | $33.85 | $42.28 | +73.82% |
| June, 2030 | $46.01 | $34.63 | $47.61 | +123.70% |
| July, 2030 | $56.77 | $45.82 | $59.29 | +176.00% |
| August, 2030 | $71.75 | $60.13 | $81.15 | +248.80% |
| September, 2030 | $65.52 | $65.25 | $75.55 | +218.51% |
| October, 2030 | $48.94 | $47.76 | $65.79 | +137.92% |
| November, 2030 | $32.46 | $30.27 | $49.50 | +57.80% |
| December, 2030 | $33.55 | $27.15 | $39.85 | +63.10% |
2.02%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):